This test showed that both biomarkers statistically significantly decrease the risk of lung cancer: for BCHE, Exp(β) = 0.525 (p < 0.05) and for GPx3 Exp(β) = 0.735 (p = 0.059). Here, GPX3 is linked to lung cancer.